Process Development and Scale-Up of AZD7545, a PDK Inhibitor

被引：18

作者：

Patel, Bharti ^{[1
]}

Firkin, Catherine R. ^{[1
]}

Snape, Evan W. ^{[1
]}

Jenkin, Shelley L. ^{[1
]}

Brown, David ^{[1
]}

Chaffey, Julian G. K. ^{[1
]}

Hopes, Philip A. ^{[1
]}

Reens, Carl D. ^{[2
]}

Butters, Mike ^{[1
]}

Moseley, Jonathan D. ^{[1
]}

机构：

[1] AstraZeneca, Avlon Works, Proc Res & Dev, Bristol BS10 7ZE, Avon, England

[2] AstraZeneca, R&D Charnwood, Dev Manufacture, Loughborough LE11 5RH, Leics, England

来源：

ORGANIC PROCESS RESEARCH & DEVELOPMENT | 2012年 / 16卷 / 03期

关键词：

TREGOE DECISION-ANALYSIS; FACILE SYNTHESIS; ACIDS; TOOL;

D O I：

10.1021/op2003419

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

A brief comparison of the early manufacturing routes to AZD7545 is given. Process development of the preferred long-term manufacturing route is reported in detail, and changes from the initial kilogram-scale route are discussed. Scale-up experience from the pilot-plant manufacture is included in the discussion of each stage. Noteworthy aspects throughout the development of AZD7545 concerned chemical hazards, mechanisms, analysis, and impurities, upon which this case study will focus.

引用

页码：447 / 460

页数：14

共 50 条

[1] AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2
Morrell, JA
Orme, J
Butlin, RJ
Roche, TE
Mayers, RM
Kilgour, E
BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 1168 - 1170
[2] Kepner-Tregoe Decision Analysis as a Tool To Aid Route Selection. Part 2. Application to AZD7545, a PDK Inhibitor
Moseley, Jonathan D.
Brown, David
Firkin, Catherine R.
Jenkin, Shelley L.
Patel, Bharti
Snape, Evan W.
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2008, 12 (06) : 1044 - 1059
[3] Development and Scale-up of a Route to ATR Inhibitor AZD6738
Goundry, William R. F.
Dai, Kuangchu
Gonzalez, Miguel
Legg, Daniel
O'Kearney-McMullan, Anne
Morrison, James
Stark, Andrew
Siedlecki, Paul
Tomlin, Paula
Yang, Jianbo
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2019, 23 (07) : 1333 - 1342
[4] The novel pyruvate dehydrogenase activator AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2.
Kilgour, E
Orme, JP
Morrell, JA
Butlin, RJ
Chauhan, U
Davies, R
Mayers, RM
Roche, TE
Roberts, D
Sanchez, L
Timms, D
Yan, X
Holloway, BR
DIABETOLOGIA, 2003, 46 : A295 - A295
[5] Development of a Continuous Flow Scale-Up Approach of Reflux Inhibitor AZD6906
Gustafsson, Tomas
Sorensen, Henrik
Ponten, Fritiof
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (05) : 925 - 929
[6] Process Development and Scale-Up of an Hsp90 Inhibitor
Duan, Shengquan
Venkatraman, Sripathy
Hong, Xuechuan
Huang, Kenneth
Ulysse, Luckner
Mobele, Bingidimi I.
Smith, Alexander
Lawless, Lawrence
Locke, Andrew
Garigipati, Ravi
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2012, 16 (11) : 1787 - 1793
[7] Process Development and Scale-Up of the Novel β-Lactamase Inhibitor WCK 6395
Tamboli, Yasinalli
Kilbile, Jaydeo T.
Deshmukh, Vikas
Rane, Vipul
Tadiparthi, Ravikumar
Yeole, Ravindra
Merwade, Arvind Y.
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2023, 27 (03) : 496 - 504
[8] Process Development and Scale-Up of a Benzoxazepine-Containing Kinase Inhibitor
Naganathan, Sriram
Andersen, Denise L.
Andersen, Neil G.
Lau, Stephen
Lohse, Anders
Sorensen, Mads Detlef
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2015, 19 (07) : 721 - 734
[9] Discovery, process development, and scale-up of a benzoxazepine-containing mtor inhibitor
Leahy J.W.
Naganathan S.
Andersen D.L.
Andersen N.G.
Lau S.
ACS Symposium Series, 2018, 1307 : 249 - 285
[10] Process Development and Scale-up of a β-Secretase Inhibitor via a Stereospecific Jocic Reaction
Henegar, Kevin E.
Lira, Ricardo
Kim, Hui
Gonzalez-Hernandez, Juan
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2013, 17 (07) : 985 - 990

← 1 2 3 4 5 →